Literature DB >> 25335442

DXA-measured visceral adipose tissue predicts impaired glucose tolerance and metabolic syndrome in obese Caucasian and African-American women.

X Bi1, L Seabolt2, C Shibao3, M Buchowski2, H Kang4, C D Keil2, R Tyree2, H J Silver2.   

Abstract

BACKGROUND/
OBJECTIVES: New methods to measure visceral adipose tissue (VAT) by dual-energy X-ray absorptiometry (DXA) may help discern sex, race and phenotype differences in the role of VAT in cardiometabolic risk. This study was designed (1) to compare relationships of DXA-VAT, anthropometric and body composition variables with cardiometabolic risk factors in obese women; (2) to determine which variables most robustly predict impaired glucose tolerance (IGT) and metabolic syndrome (MetSx); and (3) to determine thresholds for DXA-VAT by race. SUBJECTS/
METHODS: VAT mass (g) and volume (cm(3)) were measured in 229 obese (body mass index (BMI), 30-49.9) women aged 21-69 years of European-American (EA=123) and African-American (AA=106) descent using the CoreScan algorithm on a Lunar iDXA scanner. Linear regression modeling and areas under the curve (AUC of ROC (receiver operating characteristic) curves) compared relationships with cardiometabolic risk. Bootstrapping with LASSO (least absolute shrinkage and selection operator) regression modeling determined thresholds and predictors of IGT and MetSx.
RESULTS: DXA-VAT explained more of the variance in triglycerides, blood pressure, glucose and homeostatic model assessment-insulin resistance (HOMA-IR) compared with anthropometric and other body composition variables. DXA-VAT also had the highest AUC for IGT (0.767) and MetSx (0.749). Including race as a variable and the interaction between VAT and race in modeling did not significantly change the results. Thresholds at which the probability of developing IGT or MetSx was⩾50% were determined separately for AA women (IGT: 2120 cm(3); MetSx: 1320 cm(3)) and EA women (IGT: 2550 cm(3); MetSx: 1713 cm(3)). The odds for IGT or MetSx were fourfold greater with each standard deviation increase in DXA-VAT.
CONCLUSIONS: DXA-VAT provides robust clinical information regarding cardiometabolic risk in AA and EA obese women and offers potential utility in the risk reduction interventions.

Entities:  

Mesh:

Year:  2014        PMID: 25335442      PMCID: PMC4748955          DOI: 10.1038/ejcn.2014.227

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  68 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Measurement of abdominal fat by magnetic resonance imaging, dual-energy X-ray absorptiometry and anthropometry in non-obese men and women.

Authors:  E G Kamel; G McNeill; T S Han; F W Smith; A Avenell; L Davidson; P Tothill
Journal:  Int J Obes Relat Metab Disord       Date:  1999-07

3.  "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.

Authors:  P Björntorp
Journal:  Arteriosclerosis       Date:  1990 Jul-Aug

4.  Estimating intraabdominal adipose tissue in women by dual-energy X-ray absorptiometry.

Authors:  M S Treuth; G R Hunter; T Kekes-Szabo
Journal:  Am J Clin Nutr       Date:  1995-09       Impact factor: 7.045

5.  Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells.

Authors:  Teresa Coll; Xavier Palomer; Francisco Blanco-Vaca; Joan Carles Escolà-Gil; Rosa M Sánchez; Juan C Laguna; Manuel Vázquez-Carrera
Journal:  Endocrinology       Date:  2009-12-18       Impact factor: 4.736

6.  Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.

Authors:  Simin Liu; JoAnn E Manson; Julie E Buring; Meir J Stampfer; Walter C Willett; Paul M Ridker
Journal:  Am J Clin Nutr       Date:  2002-03       Impact factor: 7.045

Review 7.  The burden of cardiovascular disease: following the link from hypertension to myocardial infarction and heart failure.

Authors:  Henry R Black
Journal:  Am J Hypertens       Date:  2003-09       Impact factor: 2.689

8.  Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Authors:  Luigi Fontana; J Christopher Eagon; Maria E Trujillo; Philipp E Scherer; Samuel Klein
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

9.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

10.  The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1994-04       Impact factor: 9.461

View more
  24 in total

1.  Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors.

Authors:  Patricia Sheean; Claudia Arroyo; Jennifer Woo; Linda Schiffer; Melinda Stolley
Journal:  J Acad Nutr Diet       Date:  2018-01-02       Impact factor: 4.910

2.  Anthropometric discriminators of type 2 diabetes among White and Black American adults.

Authors:  Dale S Hardy; Devita T Stallings; Jane T Garvin; Francine C Gachupin; Hongyan Xu; Susan B Racette
Journal:  J Diabetes       Date:  2016-07-12       Impact factor: 4.006

3.  DXA-Determined Regional Adiposity Relates to Insulin Resistance in a Young Adult Population with Overweight andObesity.

Authors:  Anne E Bantle; Tyler A Bosch; Donald R Dengel; Qi Wang; Douglas G Mashek; Lisa S Chow
Journal:  J Clin Densitom       Date:  2018-06-07       Impact factor: 2.617

Review 4.  Diagnostic imaging in the management of patients with metabolic syndrome.

Authors:  Seo Rin Kim; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-22       Impact factor: 7.012

Review 5.  Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Glob Heart       Date:  2017-05-17

6.  Does Visceral Fat Estimated by Dual-Energy X-ray Absorptiometry Independently Predict Cardiometabolic Risks in Adults?

Authors:  Hiroyuki Sasai; Robert J Brychta; Rachel P Wood; Megan P Rothney; Xiongce Zhao; Monica C Skarulis; Kong Y Chen
Journal:  J Diabetes Sci Technol       Date:  2015-03-23

7.  Comparison of Associations of DXA and CT Visceral Adipose Tissue Measures With Insulin Resistance, Lipid Levels, and Inflammatory Markers.

Authors:  John T Schousboe; Lisa Langsetmo; Ann V Schwartz; Brent C Taylor; Tien N Vo; Allyson M Kats; Elizabeth Barrett-Connor; Eric S Orwoll; Lynn M Marshall; Iva Miljkovic; Nancy E Lane; Kristine E Ensrud
Journal:  J Clin Densitom       Date:  2017-02-24       Impact factor: 2.617

8.  Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.

Authors:  Sohrab Nobarani; Fariba Alaei-Shahmiri; Rokhsareh Aghili; Mojtaba Malek; Hossein Poustchi; Maryam Lahouti; Mohammad E Khamseh
Journal:  Dig Dis Sci       Date:  2021-03-31       Impact factor: 3.199

9.  Stabilization of BMIz Score is Associated with a Decrease in Visceral Fat in Children with Obesity.

Authors:  Yashoda Naik; David B Allen; Jens Eickhoff; Aaron L Carrel
Journal:  Horm Metab Res       Date:  2020-06-02       Impact factor: 2.936

10.  Unique Metabolic Features of Adults Discordant for Indices of Insulin Resistance.

Authors:  Yilin Song; Esben Søndergaard; Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.